Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Sepsis Diagnostic Market Status and Forecast (2016-2027)
  • 1.3.2 Global Sepsis Diagnostic Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Sepsis Diagnostic Supply by Company

• 2.1 Global Sepsis Diagnostic Sales Value by Company
• 2.2 Sepsis Diagnostic Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Sepsis Diagnostic Market Status by Category

• 3.1 Sepsis Diagnostic Category Introduction
  • 3.1.1 Laboratory Tests
  • 3.1.2 Point-of-care Tests
• 3.2 Global Sepsis Diagnostic Market by Category
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional Sepsis Diagnostic Market Status by End User/Segment

• 4.1 Sepsis Diagnostic Segment by End User/Segment
  • 4.1.1 Hospitals
  • 4.1.2 Pathology & Reference Laboratories
• 4.2 Global Sepsis Diagnostic Market by End User/Segment
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global Sepsis Diagnostic Market Status by Region

• 5.1 Global Sepsis Diagnostic Market by Region
• 5.2 North America Sepsis Diagnostic Market Status
• 5.3 Europe Sepsis Diagnostic Market Status
• 5.4 Asia Pacific Sepsis Diagnostic Market Status
• 5.5 Central & South America Sepsis Diagnostic Market Status
• 5.6 Middle East & Africa Sepsis Diagnostic Market Status

6 North America Sepsis Diagnostic Market Status

• 6.1 North America Sepsis Diagnostic Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Sepsis Diagnostic Market Status

• 7.1 Europe Sepsis Diagnostic Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Sepsis Diagnostic Market Status

• 8.1 Asia Pacific Sepsis Diagnostic Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Sepsis Diagnostic Market Status

• 9.1 Central & South America Sepsis Diagnostic Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Sepsis Diagnostic Market Status

• 10.1 Middle East & Africa Sepsis Diagnostic Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Major Downstream Customers Analysis

• 11.1 Customer One Analysis
• 11.2 Customer Two Analysis
• 11.3 Customer Three Analysis
• 11.4 Customer Four Analysis

12 Global Sepsis Diagnostic Market Forecast by Category and by End User/Segment

• 12.1 Global Sepsis Diagnostic Sales Value Forecast (2022-2027)
• 12.2 Global Sepsis Diagnostic Forecast by Category
• 12.3 Global Sepsis Diagnostic Forecast by End User/Segment

13 Global Sepsis Diagnostic Market Forecast by Region/Country

• 13.1 Global Sepsis Diagnostic Market Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Thermo Fisher Scientific (US)
  • 14.1.1 Company Information
  • 14.1.2 Sepsis Diagnostic Product Introduction
  • 14.1.3 Thermo Fisher Scientific (US) Sepsis Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 T2 Biosystems (US)
  • 14.2.1 Company Information
  • 14.2.2 Sepsis Diagnostic Product Introduction
  • 14.2.3 T2 Biosystems (US) Sepsis Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Roche (Switzerland)
  • 14.3.1 Company Information
  • 14.3.2 Sepsis Diagnostic Product Introduction
  • 14.3.3 Roche (Switzerland) Sepsis Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Luminex (US)
  • 14.4.1 Company Information
  • 14.4.2 Sepsis Diagnostic Product Introduction
  • 14.4.3 Luminex (US) Sepsis Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 EKF (US)
  • 14.5.1 Company Information
  • 14.5.2 Sepsis Diagnostic Product Introduction
  • 14.5.3 EKF (US) Sepsis Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Danaher (US)
  • 14.6.1 Company Information
  • 14.6.2 Sepsis Diagnostic Product Introduction
  • 14.6.3 Danaher (US) Sepsis Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 CytoSorbents (US)
  • 14.7.1 Company Information
  • 14.7.2 Sepsis Diagnostic Product Introduction
  • 14.7.3 CytoSorbents (US) Sepsis Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Bruker (US)
  • 14.8.1 Company Information
  • 14.8.2 Sepsis Diagnostic Product Introduction
  • 14.8.3 Bruker (US) Sepsis Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 bioMerieux (France)
  • 14.9.1 Company Information
  • 14.9.2 Sepsis Diagnostic Product Introduction
  • 14.9.3 bioMerieux (France) Sepsis Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 Becton, Dickinson and Company (US)
  • 14.10.1 Company Information
  • 14.10.2 Sepsis Diagnostic Product Introduction
  • 14.10.3 Becton, Dickinson and Company (US) Sepsis Diagnostic Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.10.4 SWOT Analysis
• 14.11 Abbott (US)

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Sepsis Diagnostic market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Sepsis Diagnostic market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Laboratory Tests
Point-of-care Tests

Segmented by End User/Segment
Hospitals
Pathology & Reference Laboratories

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Thermo Fisher Scientific (US)
T2 Biosystems (US)
Roche (Switzerland)
Luminex (US)
EKF (US)
Danaher (US)
CytoSorbents (US)
Bruker (US)
bioMerieux (France)
Becton, Dickinson and Company (US)
Abbott (US)